- Home
- NKTR vs SGC Comparison
NKTR vs SGC Comparison
Compare NKTR & SGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NKTR
- SGC
- Stock Information
- Founded
- NKTR 1990
- SGC 1920
- Country
- NKTR United States
- SGC United States
- Employees
- NKTR N/A
- SGC N/A
- Industry
- NKTR Biotechnology: Pharmaceutical Preparations
- SGC Apparel
- Sector
- NKTR Health Care
- SGC Consumer Discretionary
- Exchange
- NKTR Nasdaq
- SGC Nasdaq
- Market Cap
- NKTR 160.4M
- SGC 163.3M
- IPO Year
- NKTR 1994
- SGC N/A
- Fundamental
- Price
- NKTR $0.72
- SGC $9.86
- Analyst Decision
- NKTR Strong Buy
- SGC Strong Buy
- Analyst Count
- NKTR 6
- SGC 3
- Target Price
- NKTR $4.92
- SGC $17.00
- AVG Volume (30 Days)
- NKTR 1.9M
- SGC 48.8K
- Earning Date
- NKTR 05-08-2025
- SGC 05-08-2025
- Dividend Yield
- NKTR N/A
- SGC 5.66%
- EPS Growth
- NKTR N/A
- SGC N/A
- EPS
- NKTR N/A
- SGC 0.45
- Revenue
- NKTR $87,248,000.00
- SGC $563,931,000.00
- Revenue This Year
- NKTR N/A
- SGC $1.02
- Revenue Next Year
- NKTR N/A
- SGC $3.98
- P/E Ratio
- NKTR N/A
- SGC $21.95
- Revenue Growth
- NKTR N/A
- SGC 2.28
- 52 Week Low
- NKTR $0.43
- SGC $9.11
- 52 Week High
- NKTR $1.52
- SGC $21.80
- Technical
- Relative Strength Index (RSI)
- NKTR 54.57
- SGC 43.41
- Support Level
- NKTR $0.61
- SGC $9.63
- Resistance Level
- NKTR $0.74
- SGC $10.02
- Average True Range (ATR)
- NKTR 0.06
- SGC 0.37
- MACD
- NKTR 0.01
- SGC 0.00
- Stochastic Oscillator
- NKTR 81.79
- SGC 20.33
About NKTR Nektar Therapeutics
Nektar Therapeutics is a biopharmaceutical company. It has wholly-owned research and development pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. In oncology, The company is focused on activating the immune system natural tumor-fighting mechanisms, and it will be studying several immuno-oncology drug candidates in the clinic for a variety of cancer indications. In immunology, it is focused on addressing imbalances in the immune system to restore the body's self-tolerance mechanisms and achieve immune homeostasis. In virology, the company believes selective immuno-modulators can be useful in addressing viral infections in people. The group derives revenue from the United States and the Rest of the World.
About SGC Superior Group of Companies Inc.
Superior Group Of Companies Inc designs apparel products. The company's operating segment includes Branded Products; Healthcare Apparel and Contact Centers. It generates maximum revenue from the Branded Products segment. The Branded Products segment produce and sell customized merchandising solutions, promotional products and branded uniform programs to customers.